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INTRODUCTION/OBJECTIVES: Systemic sclerosis, or scleroderma, is a rheumatic disease characterized by autoimmunity, 
vasculopathy, and fibrosis of the skin and several internal organs. In the present study, our aim was to assess the skin alterations in 
animals with scleroderma during the first stages of disease induction. 
METHODS: To induce scleroderma, female New Zealand rabbits (n = 12) were subcutaneously immunized with 1 mg/ml of 
collagen V (Col V) in complete Freund’s adjuvant, twice with a thirty-day interval. Fifteen days later, the animals received an 
intramuscular booster with type V collagen in incomplete Freund’s adjuvant, twice with a fifteen-day interval. The control group 
was inoculated with 1 ml of 10 mM acetic acid solution diluted with an equal amount of Freund’s adjuvant. Serial dorsal skin 
biopsies were performed at 7, 15, and 30 days and stained with H&E, Masson’s trichrome and Picrosírius for morphological and 
morphometric analyses. 
RESULTS: Immunized rabbits presented a significant increase in collagen in skin collected seven days after the first immuniza-
tion (p=0.05). 
CONCLUSION: The results from this experimental model may be very important to a better understanding of the pathogenic 
mechanisms involved in the beginning of human SSc. Therapeutic protocols to avoid early remodeling of the skin may lead to 
promising treatments for SSc in the future. 
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INTRODUCTION
Systemic sclerosis (SSc), or scleroderma, is a disease of 
unknown etiology characterized by vascular involvement, 
autoimmunity, and fibrosis of the skin and internal organs.1-2 
Thickening of the skin is the hallmark of the disease,3 and 
the extent of cutaneous involvement has been shown to 
influence patient abilities,4 activities,5 and outcomes.6
The most prominent pathologic manifestation of 
the disease is an accumulation of extracellular matrix 
components, predominantly collagen types I and III,7-12 but 
also types VI13 and VII.14
The current authors have previously described changes in 
anatomical distribution of collagen and its consequences;15 
they have also described an experimental model of SSc in 
rabbits after immunization with type V collagen (COL V)16, 
but not with other types of collagen. These animals developed 
progressive fibrosis and vascular involvement in all organs 
usually affected by SSc.16-20 Antinuclear, anti-Scl7021, and 
anti-collagen type I, III, and V antibodies were found in the 
serum of these animals, as were immunocomplexes.20 The 
same authors suggested that the fibrosis development in these 
animals at 75 and 120 days following initial immunization 
with Col V was a consequence of an antigen versus antibody 
reaction occurring at the endothelial cell surface. They 
hypothesized that immunocomplexes deposited at the 
endothelial cell layer could activate these cells to release pro-
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inflammatory mediators such as TGF beta and endothelin, 
stimulating fibroblasts to synthesize collagen. However, it 
was uncertain whether other mechanisms could be involved 
in the remodeling process and when these mechanisms started 
in the experimental model. The aim of the present study was 
to evaluate the amount of collagen in the skin of rabbits at 
7, 15, and 30 days after immunization with Col V with the 
purpose of verifying the changes during the early stage of 
immunization to induce experimental SSc. It was hypothesized 
that the augmentation of collagenous fibers occurs early in the 
skin of rabbits after immunization with collagen V.
MATERIALS AND METHODS
Complete Immunization Protocol 
To induce experimental SSc in healthy New Zealand 
female rabbits, the complete immunization protocol (Figure 
1) included four inoculations. The first was a subcutaneous 
(sc) injection of 1 mg of Col V isolated from human placenta, 
diluted in 1 ml of 10 mM acetic acid and added to an equal 
amount of complete Freund’s adjuvant (Sigma Chemical Co.; 
St. Louis, Missouri, USA). The second inoculation occurred 
30 days later via an identical subcutaneous injection. Fifteen 
days after the second subcutaneous injection, the rabbits 
received one reinforcement dose of 1 mg of Col V plus 1 
ml of incomplete Freund’s adjuvant intramuscularly (third 
inoculation). Finally, a second identical reinforcement 
(fourth inoculation) was administrated after another 15 
days.16-18 
Early Stage of the Immunization Protocol
To study the early stage of immunization (Figure 1), 
seventy-day-old healthy New Zealand female rabbits (N=12) 
received 1 mg/ml of Col V plus complete Freund’s adjuvant 
subcutaneously (sc). After being anesthetized, each animal 
was subjected to a series of sequential skin biopsies carried 
out in distinct dorsal regions at 7 (N=4, group 7 days), 15 
(N=4, group 15 days), and 30 (N=4, group 30 days) days 
after immunization; the animals were sedated with an 
aqueous solution of 2% cloridrate of 2-(2, 6-xylidine)-5, 
6-dihydro-4H-1,3-tiazine (Rompum, Bayer do Brasil S. 
A), and anesthetized after five minutes with 1 M ketamine 
cloridrate (Ketalar, Park-Davis). The samples collected 
were immersed in 10% formaldehyde for 24 hrs, embedded 
in paraffin, cut into 3-4 µm-thick slices, and stained with 
hematoxylin and eosin (H&E), Masson’s trichrome, and 
Picrosirius.
Control groups were represented by rabbits inoculated 
with 1 ml of 10 mM acetic acid solution diluted with an 
equal amount of complete Freund’s adjuvant, with the skin 
sample collection carried out during the same periods used 
for the study groups (7, 15, and 30 days).
 
Histomorphometric analysis
To characterize the collagenous fibers in the dermis, 
Masson’s trichrome was used to stain some of the collagen-
containing fibers in blue. 
Collagen fiber density was evaluated in the dermis of 
each biopsy specimen after the first COL V inoculation by 
the Picrosirius polarization method.22 This method permits 
determination of the location of collagen-containing fibers 
in the skin by intensifying the normal birefringence of 
collagenous fibers. The content of collagen fibers in the 
dermis was determined by an image analysis system in 
which a charge-coupled device Sony DXC-101 camera is 
coupled to a Zeiss Axioplan microscope, from which the 
images are then sent to a monitor (Trinitron Sony). By means 
of a digitizing system (Oculus TCX, Coreco; St Laurent, 
Quebec, Canada) inserted into a computer (Pentium, 133 
MHz), the images were processed by software (Bioscan-
Optimas 5.1; Bioscan, Edmonds, Washington, DC, USA). 
The enhancement of collagen birefringence promoted by the 
Picrosirius polarization method is specific to collagenous 
structures composed of aggregates of orientated molecules. 
The threshold for collagenous fibers was established for each 
Figure 1 - Illustration of the immunization protocol and temporal skin biopsies. Col V=Collagen V; CFA=Complete Freund’s adjuvant; IFA=Incomplete 
Freund’s adjuvant; SC= Subcutaneous; IM=Intramuscular.
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slide after enhancing the contrast up to a point at which the 
fibers were easily identified as birefringent (collagen) bands. 
The area occupied by the fibers was determined by digital 
densitometric recognition via adjustment of the threshold level 
of the measurement to include all fibers of the collagenous 
system. Collagen content was measured in the distinct layers 
of the dermis, and is expressed as the relationship between the 
quantity of collagen fibers divided by the total area of dermis 
studied. The area of dermis in each specimen was carefully 
measured in the image analysis system using a cursor that 
permits free determination of the area below the epidermis and 
basement membrane. The results display the amount of fibers 
in the collagenous systems (in area) per total area of dermis, 
and are expressed as a fraction.
Statistical analysis
The quantitative results are expressed as means ± SD. 
The t-test was used to verify differences between the means 
of the study and control groups. SPSS version 14.0 software 
was used for all statistical analyses, and the significance 
level was set at 5%.23 
RESULTS
Histological analysis
Figures 2A-2F, 3A-3F, and 4A-4F show skin samples 
obtained from normal and immunized rabbits that were 
Figure 2 - Panels (A - C) depict control rabbit skin samples stained with H&E collected after 7, 15, and 30 days, respectively. Panels (D - F) depict skin 
samples of immunized rabbits stained with H&E collected after 7, 15, and 30 days, respectively. Magnification: 40X.
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stained with H&E, Masson’s trichrome, and Picrosírius 
under polarized light, respectively. Preservation of the 
architecture in the dermis can be observed in control 
animals (Figure 2A-C and Figure 3A-C), coincident with 
the weak yellow birefringence of the fibers (Figure 4A-C). 
In contrast, the skin of rabbits examined seven days after 
the first inoculation (Figure 2D-F, Figure 3D-F) presented 
distortion of the architecture and increased reddish-yellow 
birefringence in the dermis, indicating the presence of thick 
fibers characteristic of the fibrotic process (Figure 4D-F). 
Histomorphometric Analysis
Table 1 shows the distribution of the means and standard 
deviation values according to measurements of collagen at 
days 7, 15, and 30. 
A significant increase in collagen fibers was found in 
the dermis of animals belonging to the immunized group at 
seven days compared to controls (9.72±3.41 vs. 6.54±0.94; 
p=0.05) (Figure 5). Additionally, the collagen fiber density 
in the dermis of animals belonging to the 15 and 30-day 
Figure 3 - Panels (A - C) depict control rabbit skin samples stained with Masson’s trichrome collected after 7, 15, and 30 days, respectively. Panels (D - F) 
depict skin samples of immunized rabbits stained with Masson’s trichrome collected after 7, 15, and 30 days, respectively. Magnification: 40X.
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Figure 4 - Panels (A - C) depict control rabbit skin samples stained by Picrosirius and observed under polarized light collected after 7, 15, and 30 days, 
respectively. Panels (D - F) depict skin samples of immunized rabbits stained by the Picrosirius method and observed under polarized light collected after 
7, 15, and 30 days, respectively. Magnification: 40X.
groups was also increased when compared to the control 
group, although the differences did not reach statistical 
significance. 
DISCUSSION
In the present study, we demonstrated that the increase 
in collagen is observed from seven days after the first 
immunization. The increased collagen density persists 15 
and 30 days after the first immunization. 
This finding refutes the idea that collagen deposition 
is due to antibody production because, in the standard 
immunization process, the antibodies are usually present 
15-30 days after the first immunization. In fact, we 
have previously found that in this early stage, the 
anti-collagen I, III, and V antibodies are not present 
(unpublished data). These findings are also supported 
by previous work using the same experimental model 
that demonstrated the presence of auto-immunity by 
detecting anti-nuclear (ANA) and anti-collagen I, III, 
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Figure 5 - Box plots illustrating the significant difference (p=0.05) in the 
degree of collagen thickening between control and immunized animal 
samples collected after seven days.
Table 1 - Measurements analysis of collagen fibers in the 
dermis of animals in the immunized and control groups at 
7, 15, and 30 days.
Collagen fibers Mean Standard Deviation P*
Group 7 days
Control group 7 days
9.72
6.54
3.41
0.94
0,05*
Group 15 days
Control group 15 days
10.24
8.35
2.77
1.49
0,17
Group 30 days
Control group 30 days
9.59
8.07
2.75
1.17
0,24
Results analyzed by the t-test to verify differences between the means of the 
measurements of collagen fibers in immunized and control groups at 7, 15, 
and 30 days at a significance level of 0.05. *Statistically significant.
IV, and V antibodies 75 and 120 days after the first 
sensitization.20,21 
The increased collagen content detected during early 
stages of immunization ceased at the end of animal 
immunization. However, morphological analysis 75 and 
120 days after the first sensitization demonstrated that 
skin remodeling by collagen deposit was progressive.17 
Furthermore, immunological abnormalities emerged 
during the late stage of animal disease and, to reinforce 
the continuity of the inflammatory process, we proved 
that circulating immunocomplexes do not diminish when 
Col V immunization ceases.20 At this point, one question 
emerged: how can the perpetuation of histological damage 
and continuous collagen synthesis be explained? The answer 
derives from the particularities of Col V. It is a hidden 
molecule, found composing heterotypic fibrils together with 
collagen types I and III. Beyond this aspect, Col V is highly 
immunogenic, since it preserves globular and telopeptide 
domains. The delayed animal immunization with this protein 
probably promotes endothelial-basement rupture and further 
exposition of Col V epitopes normally found hidden inside 
heterotypic fibrils. This process generates fragments of Col 
V (neoantigens). Most likely, these neoantigens will activate 
the immunological system to produce higher amounts 
of anti-collagen V antibodies, increasing the presence of 
circulating immunocomplexes, which in turn perpetuate 
continuous vascular aggression and collagen synthesis. 
Finally, the results obtained using this experimental 
model may be very important to a better understanding of the 
pathogenic mechanisms involved in the beginning of human 
SSc. Therapeutic protocols to avoid early remodeling of the 
skin may lead to promising treatments for SSc in the future. 
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